Sort by
Refine Your Search
-
80%-100%, Zurich, fixed-term ETH Zurich is one of the world’s leading universities specialising in science and technology. It is renowned for its excellent education, its cutting-edge fundamental
-
interdisciplinary scientists and engineers to develop and apply open-source software in a diverse range of research topics. Profile We are looking for an experienced bioinformatics software engineer to engage in
-
, control engineering, and immunoengineering. This position is part of our newly funded ERC Advanced Grant, which aims to develop genetically engineered feedback control circuits in human T cells to tackle
-
80%-100%, Zurich, fixed-term ETH Zurich is one of the world’s leading universities specialising in science and technology. It is renowned for its excellent education, its cutting-edge fundamental
-
Engineering Group, please visit our website . Questions regarding the position should be directed to Patrick Alberto Rühs (patrick.ruehs@hest.ethz.ch) (no applications). We would like to emphasize that the pre
-
-handed propulsion, and delivering a smooth, intuitive movement experience. We started as a Wyss Zurich Project in 2025 and are now growing our team to bring this groundbreaking technology to market and
-
Zürich ETH Zurich is one of the world’s leading universities specialising in science and technology. We are renowned for our excellent education, cutting-edge fundamental research and direct transfer
-
degree in the fields of transportation, civil engineering, computer science, urban analytics, spatial planning, geography, geoinformation, psychology or an equivalent qualification. Experience with first
-
) at the Institute of Biomedical Engineering at ETH Zurich. The research in the newly established Multiphase Fluid Dynamics group at ETH Zurich examines both fundamental and applied questions in various small-scale
-
Cell Dynamics Lab combines a wide variety of disciplines and techniques to answer outstanding questions in cancer and stem cell research. Our interdisciplinary research group combines organoid technology